adult acute myeloid leukemia with inv(16)(p13;q22)
Showing 9951 - 9975 of >10,000
Call for On-site Care of the Pre-hospital Service of the Mobile Emergency Unit of Hospital Israelita Albert Einstein Trial (No
Completed
- Patients Emergency On-site Care by Mobile Emergency Unit
- No teleconsultation during the ambulance journey
- Teleconsultation during the ambulance journey
-
São Paulo, BrazilHospital Israelita Abert Einstein
Jan 26, 2023
OCD Trial (Bergen 4-Day Treatment (B4DT), Gold standard cognitive behavioral therapy (gold standard CBT))
Not yet recruiting
- Obsessive-Compulsive Disorder
- Bergen 4-Day Treatment (B4DT)
- Gold standard cognitive behavioral therapy (gold standard CBT)
- (no location specified)
Nov 3, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning, Myeloid Tumors Trial in Guangzhou (Decitabine, Busulfan (BU),
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Decitabine
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Sep 19, 2019
Multispectral Optoacoustic Tomography in Cystic Fibrosis
Not yet recruiting
- Cystic Fibrosis
- +3 more
- Acoustic Radiation Forced Impulse Imaging
- Multispectral Optoacoustic Tomography
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Sep 25, 2023
Ulcerative Colitis Trial in United States (Hyperbaric Oxygen Therapy, Sham Hyperbaric Air)
Not yet recruiting
- Ulcerative Colitis
- Hyperbaric Oxygen Therapy
- Sham Hyperbaric Air
-
Birmingham, Alabama
- +18 more
Aug 9, 2023
Gastric Retention Trial (Abdominal Massage)
Not yet recruiting
- Gastric Retention
- Abdominal Massage
- (no location specified)
Sep 25, 2023
Effectiveness of Different Scoring Systems
Not yet recruiting
- Healthy
- (no location specified)
Mar 23, 2023
Prostate Carcinoma Trial in Philadelphia (ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal
Not yet recruiting
- Prostate Carcinoma
- ultiparametric Magnetic Resonance Imaging
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 29, 2023
Chronic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)
Tooth Decay Trial in Montpellier (decayed tooth surfaces)
Completed
- Tooth Decay
- decayed tooth surfaces
-
Montpellier, FranceMOULIS
Aug 10, 2022
Biomarkers, Airway Inflammation Trial in Guangzhou (no intervention)
Not yet recruiting
- Biomarkers
- Airway Inflammation
- no intervention
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory health
May 12, 2021
COVID-19 Pneumonia, Pulmonary Rehabilitation, Pregnancy Trial in Istanbul (pulmonary rehabilitation)
Completed
- COVID-19 Pneumonia
- +2 more
- pulmonary rehabilitation
-
İstanbul, TurkeyHalime Sinem Barutcu
Nov 30, 2022
Subcutaneous Infusion of ABBV-951 to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Jun 15, 2023
Tonsillectomy, Pain, Ambulatory Trial in Amiens (Tonsillectomy, daily follow-up)
Not yet recruiting
- Tonsillectomy
- +2 more
- Tonsillectomy
- daily follow-up
-
Amiens, FranceCHU Amiens
Jun 13, 2023
Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)
Recruiting
- Alzheimer Disease
- Lemborexant 25 mg
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Feb 16, 2023
Latrodectism Trial in Ciudad de mexico (ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder
Completed
- Latrodectism
- ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL
-
Ciudad de mexico, Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Pain Trial in Brooklyn (Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg, Nebulized Sub-dissociative Dose Ketamine
Recruiting
- Pain
- Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg
- +2 more
-
Brooklyn, New YorkMaimonides Medical Center
Apr 7, 2022
Healthy Trial in Lincoln (ACH-0145228: Immediate Release, ACH-0145228: Powder-in-capsule)
Completed
- Healthy
- ACH-0145228: Immediate Release
- ACH-0145228: Powder-in-capsule
-
Lincoln, NebraskaClinical Trial Site
Dec 8, 2021
Schizophrenia Trial in Hungary, Poland (CPL500036 - low dose, CPL500036 - high dose, Placebo)
Recruiting
- Schizophrenia
- CPL500036 - low dose
- +2 more
-
Budapest, Hungary
- +7 more
May 4, 2022
Chronic Hepatitis B Trial in Worldwide (VIR-2218, Placebo)
Dry Eye Syndromes Trial in France, Poland, Spain (Cationorm Pro, Vismed)
Recruiting
- Dry Eye Syndromes
- Cationorm Pro
- Vismed
-
La Rochefoucauld, France
- +9 more
May 16, 2022